141 related articles for article (PubMed ID: 25426543)
1. Cell reprogramming for skeletal dysplasia drug repositioning.
Karagiannis P; Tsumaki N
Cell Cycle; 2014; 13(24):3791-2. PubMed ID: 25426543
[No Abstract] [Full Text] [Related]
2. Bone: statin therapy for skeletal dysplasia.
Sargent J
Nat Rev Endocrinol; 2014 Dec; 10(12):701. PubMed ID: 25265980
[No Abstract] [Full Text] [Related]
3. Disease models: Statins give bone growth a boost.
Olsen BR
Nature; 2014 Sep; 513(7519):494-5. PubMed ID: 25231860
[No Abstract] [Full Text] [Related]
4. A new prescription for growth? Statins, cholesterol and cartilage homeostasis.
Bush JR; Bérubé NG; Beier F
Osteoarthritis Cartilage; 2015 Apr; 23(4):503-6. PubMed ID: 25595698
[No Abstract] [Full Text] [Related]
5. Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.
Yamashita A; Morioka M; Kishi H; Kimura T; Yahara Y; Okada M; Fujita K; Sawai H; Ikegawa S; Tsumaki N
Nature; 2014 Sep; 513(7519):507-11. PubMed ID: 25231866
[TBL] [Abstract][Full Text] [Related]
6. Intermittent PTH (1-34) injection rescues the retarded skeletal development and postnatal lethality of mice mimicking human achondroplasia and thanatophoric dysplasia.
Xie Y; Su N; Jin M; Qi H; Yang J; Li C; Du X; Luo F; Chen B; Shen Y; Huang H; Xian CJ; Deng C; Chen L
Hum Mol Genet; 2012 Sep; 21(18):3941-55. PubMed ID: 22634226
[TBL] [Abstract][Full Text] [Related]
7. Multiplex PCR in noninvasive prenatal diagnosis for FGFR3-related disorders.
Terasawa S; Kato A; Nishizawa H; Kato T; Yoshizawa H; Noda Y; Miyazaki J; Ito M; Sekiya T; Fujii T; Kurahashi H
Congenit Anom (Kyoto); 2019 Jan; 59(1):4-10. PubMed ID: 29542187
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype.
Camera G; Baldi M; Strisciuglio G; Concolino D; Mastroiacovo P; Baffico M
Am J Med Genet; 2001 Dec; 104(4):277-81. PubMed ID: 11754059
[TBL] [Abstract][Full Text] [Related]
9. Thanatophoric dysplasia type 1 with temporal lobe dysplasia: Report of a case along with differential diagnosis.
Mondal A; Mandal B; Das RN; Chatterjee U; Mukherjee S
Indian J Pathol Microbiol; 2021; 64(4):776-779. PubMed ID: 34673602
[TBL] [Abstract][Full Text] [Related]
10. HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasia.
Ota S; Zhou ZQ; Romero MP; Yang G; Hurlin PJ
Hum Mol Genet; 2016 Oct; 25(19):4227-4243. PubMed ID: 27506979
[TBL] [Abstract][Full Text] [Related]
11. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: clinically related skeletal dysplasias that are also related at the molecular level.
Cohen MM
Int J Oral Maxillofac Surg; 1998 Dec; 27(6):451-5. PubMed ID: 9869286
[TBL] [Abstract][Full Text] [Related]
12. Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism.
Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P
Am J Med Genet; 1996 May; 63(1):148-54. PubMed ID: 8723101
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth receptor-3 (FGFR3) G375C mutation in a case of achondroplasia and thanatophoric dysplasia phenotypic overlap.
Barton C; Sweeney E; Roberts D; McPartland J
Clin Dysmorphol; 2010 Jul; 19(3):146-149. PubMed ID: 20357663
[No Abstract] [Full Text] [Related]
14. A case of thanatophoric dysplasia type 2: a novel mutation.
Gülaşı S; Atıcı A; Çelik Y
J Clin Res Pediatr Endocrinol; 2015 Mar; 7(1):73-6. PubMed ID: 25800480
[TBL] [Abstract][Full Text] [Related]
15. Mutations causing achondroplasia and thanatophoric dysplasia alter bFGF-induced calcium signals in human diploid fibroblasts.
Nguyen HB; Estacion M; Gargus JJ
Hum Mol Genet; 1997 May; 6(5):681-8. PubMed ID: 9158142
[TBL] [Abstract][Full Text] [Related]
16. Bone dysplasia series. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: review and update.
Lemyre E; Azouz EM; Teebi AS; Glanc P; Chen MF
Can Assoc Radiol J; 1999 Jun; 50(3):185-97. PubMed ID: 10405653
[TBL] [Abstract][Full Text] [Related]
17. Atypical achondroplasia due to somatic mosaicism for the common thanatophoric dysplasia mutation R248C.
Takagi M; Kaneko-Schmitt S; Suzumori N; Nishimura G; Hasegawa T
Am J Med Genet A; 2012 Jan; 158A(1):247-50. PubMed ID: 22106050
[No Abstract] [Full Text] [Related]
18. Thanatophoric dysplasia type 1 with cloverleaf skull in a dichorionic twin.
Salinas-Torres VM
Genet Couns; 2015; 26(1):61-5. PubMed ID: 26043509
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of thanatophoric dysplasia and lethal osteogenesis imperfecta type II in Northern Ireland - a complete population study.
Donnelly DE; McConnell V; Paterson A; Morrison PJ
Ulster Med J; 2010 Sep; 79(3):114-8. PubMed ID: 22375084
[TBL] [Abstract][Full Text] [Related]
20. Increased first-trimester nuchal translucency associated with thanatophoric dysplasia type 1.
Zhen L; Pan M; Han J; Yang X; Liao C; Li DZ
J Obstet Gynaecol; 2015; 35(7):685-7. PubMed ID: 25671245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
